Rafi R. Kazi

Rafi R. Kazi, M.D., is a Clinical Assistant Professor in the Department of Pediatrics at the University of Rochester Medical Center (URMC). He specializes in Pediatric Hematology-Oncology and is affiliated with the University of Rochester Medical Faculty Group (URMFG) and Accountable Health Partners (AHP), a regional healthcare network.

• Education: M.D. from University of Arkansas College of Medicine (2014)
• Training: Pediatrics Internship (2014-2015), Residency (2015-2017), and Pediatric Hematology-Oncology Fellowship (2017-2020) at Emory University Hospital

Dr. Kazi focuses on clinical research in pediatric cancers, including acute myeloid leukemia (AML), B-cell acute lymphoblastic leukemia (B-ALL), and rhabdomyosarcoma. His work emphasizes optimizing chemotherapy regimens, targeted therapies (e.g., FLT3 inhibitors), and long-term patient outcomes. He leads multiple Phase III clinical trials, such as the comparison of standard AML therapy with CPX-351 and Gilteritinib, and the EveryChild registry protocol for childhood cancer biology studies.

As a board-certified pediatric hematologist-oncologist, Dr. Kazi's contributions are centered on advancing treatment protocols for high-risk pediatric malignancies through evidence-based research collaborations like the Children's Oncology Group.